Forbes

As peptides grow more mainstream, experts weigh in on sourcing, safety, transparency, telemedicine, and what consumers should know before starting peptide therapies.

The FDA commissioner influences vaccines, medicines, food safety, nicotine regulation, and public trust. Here’s how leadership changes at the FDA can affect everyday life.

The Andes virus outbreak on the MV Hondius cruise ship has led to lots of misinformation and disinformation about the hantavirus. Here are some of the claims spreading.

Dr. Victoria Maizes' book Heal Faster offers a science-based guide to activate the body's natural recovery capacity: from nutrition and sleep to prehab and mindfulness.

The WHO has declared a global health emergency over a rare Bundibugyo Ebola outbreak in DRC and Uganda. A doctor explains what could happen next.

WHO declared the Bundibugyo Ebola outbreak a PHEIC just 48 hours after confirmation, the fastest such designation in history. What drove the decision.

“Ghostlighting” has arisen on as a portmanteau of ghosting and gaslighting. It may be on the rise. Here's are potential reasons behind this dating trend and what to do

A new Ebola outbreak in DRC went undetected for three weeks because field diagnostics couldn't identify the Bundibugyo strain. What the delay means for the response.

The current Ebola outbreak in Congo poses a threat to the entire world, with a strain that has no therapies or approved vaccine.

The Joint Commission & AHA launched a new cyber resilience program. Here's what healthcare CIOs need to know to keep patients safe when systems go down.

PCOS has been renamed PMOS. Here's what the change means for the millions of women living with this misunderstood, often misdiagnosed condition

AI in healthcare is booming but the digital health divide is widening. How underserved communities are being tech-ignored.

A 3-hour WHO Hantavirus emergency Zoom call was held this morning, providing outbreak analysis. It seemed that for every question asked many more questions were raised.

High level resignations in protest against the push to allow sales of fruit-flavored vapes suggest a break in policy between the first and second Trump administrations.